|
Canada-QC-SAINT-JEAN-SUR-RICHELIEU Azienda Directories
|
Azienda News:
- 11 new research advances from the past year - MD Anderson Cancer Center
Over the past year, MD Anderson researchers and clinicians have investigated the gut microbiome, examined the earliest genesis of lung adenocarcinoma cells, tested new and improved therapies, and more Their breakthroughs in cancer research continue to drive forward our mission to end cancer
- ASCO 2025: Big Advancements Across the Board - Susan G. Komen®
Big advancements were announced across the board at the 2025 American Society of Clinical Oncology (ASCO) meeting Phase 3 randomized clinical trials test how well a new therapy compares to the current standard of care, and results from these studies have the potential to change how breast cancer is treated There were five presentations of new phase 3 clinical trial results for breast cancer
- Mayo Clinic experts present key cancer research findings at ASCO
The event, recognized as one of the largest gatherings in the field of cancer research, will feature 59 Mayo Clinic-authored abstracts highlighting advancements in cancer care Among the standout presentations are practice-changing studies focused on chemotherapy approaches, artificial intelligence (AI) applications in oncology, cancer care at
- MD Anderson Research Highlights for January 9, 2025
Their findings show that dose-dense chemotherapy is more effective than the standard schedule for women with early-stage ER-positive breast cancer and low endocrine activity index, and the results highlight the importance of biomarker-driven approaches in tailoring cancer therapies
- Progress in Cancer Research - NCI - National Cancer Institute
Find NCI’s collection of research advances for common cancers such as breast cancer, colorectal cancer, leukemia, lung cancer, and prostate cancer These stories describe landmark developments in cancer prevention, detection, and treatment supported by NCI funds
- One Year in Cancer Research and Much to Celebrate
NCI Director Dr Kimryn Rathmell reviews some of the most noteworthy cancer research findings from 2024, including advances in immunotherapy for children with cancer, a potential therapy for cachexia, and valuable insights into cancer biology
- What Themes Emerged in Cancer Research in 2024? | Blog | AACR
Several themes emerged in cancer research in 2024, including FDA-approved first-in-class therapeutics, advances in cancer vaccines, and more
- Cancer Treatment Research - NCI - National Cancer Institute
Researchers are working to expand its use to treat more types of cancer and better understand and manage its side effects Learn how CAR T-cell therapy works, which cancers it’s used to treat, and current research efforts
- Transforming the landscape of cancer treatment with seven promising . . .
Despite decades of research and advancements in cancer therapy, conventional treatment modalities—surgery, chemotherapy, and radiotherapy—remain essential as the cornerstone for cancer management However, their efficacy is often limited, particularly in patients with advanced metastatic disease As a result, there exists a substantial
- Reflections on Advances in Cancer Research in 2024
There have been many impactful advances in basic, translational, and clinical cancer research in 2024
|
|